The mission of every team member at Carmat is to contribute to the development of innovative artificial organs – the artificial heart today, tomorrow other vital organs – to treat millions of patients affected by advanced disease of these organs and to restore their normal life.

By sharing our expertise and through our daily actions, we seek to achieve results that will benefit first and foremost patients and physicians, but also healthcare systems, subcontractors, employees and shareholders.

Vélizy-Villacoublay, FR
Size (employees)
62 (est)+38%
Carmat was founded in 2008 and is headquartered in Vélizy-Villacoublay, FR
Report incorrect company information

Carmat Office Locations

Carmat has an office in Vélizy-Villacoublay
Show all (1)
Report incorrect company information

Carmat Financials and Metrics

Carmat Financials

Market capitalization (31-Oct-2017)

150.6 m

Closing share price (31-Oct-2017)

Carmat's current market capitalization is €150.6 m.
Show all financial metrics
Report incorrect company information